Mostrando 2 resultados de: 2
Non-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopus